Oakland, CA, United States of America

Fuguo Jiang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of California. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fuguo Jiang: Innovator in Cas9 Technology

Introduction

Fuguo Jiang is a prominent inventor based in Oakland, California. He has made significant contributions to the field of genetic engineering, particularly through his work on Cas9 technology. His innovative approach has led to advancements in the understanding and application of CRISPR systems.

Latest Patents

Fuguo Jiang holds a patent for "Cas9 crystals and methods of use thereof." This patent provides atomic structures of Cas9 with and without polynucleotides bound to it. It also includes a computer-readable medium that comprises atomic coordinates for Cas9 polypeptides in both unbound and bound configurations. The patent details crystals comprising Cas9 polypeptides and methods for engineering Cas9 polypeptides, allowing for alterations in Cas9 activity.

Career Highlights

Jiang's career is marked by his association with the University of California, where he has been able to leverage his expertise in molecular biology and genetics. His work has not only advanced scientific knowledge but has also opened new avenues for research and application in gene editing.

Collaborations

Fuguo Jiang has collaborated with notable scientists such as Samuel H. Sternberg and Martin Jinek. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field of genetic engineering.

Conclusion

Fuguo Jiang's contributions to Cas9 technology exemplify the impact of innovative thinking in science. His work continues to influence the landscape of genetic research and applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…